Security Snapshot

AMERICAN CENTY ETF TR - AVANTIS EMERGING (AVXC) Institutional Ownership

CUSIP: 02507A101

13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

53

Shares (Excl. Options)

3,101,354

Price

$63.77

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / AVANTIS EMERGING
Symbol
AVXC
Price per share
$73.60
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,101,354
Total reported value
$198,328,030
% of total 13F portfolios
0%
Share change
+470,538
Value change
+$30,024,481
Number of holders
53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • AVXC - AMERICAN CENTY ETF TR - AVANTIS EMERGING is tracked under CUSIP 02507A101.
  • 53 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 53 to 50 between Q4 2025 and Q1 2026.
  • Reported value moved from $198,328,030 to $224,502,128.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 53 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 02507A101?
CUSIP 02507A101 identifies AVXC - AMERICAN CENTY ETF TR - AVANTIS EMERGING in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 53 institutional investors reported holding 3,101,354 shares of AMERICAN CENTY ETF TR - AVANTIS EMERGING (AVXC).

Institutional Holders of AMERICAN CENTY ETF TR - AVANTIS EMERGING (AVXC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 3,292,808 $224,502,128 +$39,957,860 $67.63 50
2025 Q4 3,101,354 $198,328,030 +$30,024,481 $63.77 53
2025 Q3 2,575,727 $154,257,333 +$17,016,138 $59.93 43
2025 Q2 2,294,485 $129,726,811 +$60,815,878 $56.62 42
2025 Q1 1,237,300 $60,524,166 +$6,043,763 $48.64 29
2024 Q4 1,031,622 $51,110,167 +$3,062,704 $49.54 20
2024 Q3 901,331 $48,770,159 +$43,954,432 $54.11 18
2024 Q2 88,999 $4,664,281 +$2,567,945 $52.41 10
2024 Q1 40,000 $2,018,800 +$2,018,800 $50.47 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .